What is it? Why is it important?
The Federal Stem Cell Research Act (StRA) regulates conditions under which it is permissible for human embryonic stem cells to be derived from surplus embryos and used for research purposes.
The aim of the act is to:
- Prevent the misuse of surplus embryos and embryotic stem cells
- Protect human dignity
The act does not apply to clinical studies using embryonic stem cells for transplantation purposes.
What do I need to do?
As a SP-INV performing stem cell studies, you are required to know and comply with the requirements of the StRA act.
Read the StRA act and based on your study:
- Be familiar with the organisation of the various chapters and sections
- As applicable, tag articles you are required to comply with
Where can I get help?
Your local CTU↧ can support you with experienced staff regarding this topic
Basel, Departement Klinische Forschung, CTU, dkf.unibas.ch
Lugano, Clinical Trials Unit, CTU-EOC, www.ctueoc.ch
Bern, Clinical Trials Unit, CTU, www.ctu.unibe.ch
Geneva, Clinical Research Center, CRC, crc.hug.ch
Lausanne, Clinical Research Center, CRC, www.chuv.ch
St. Gallen, Clinical Trials Unit, CTU, www.kssg.ch
Zürich, Clinical Trials Center, CTC, www.usz.ch
StRA – see in particular article
- Art. 1 Subject, purpose and scope